IMMX
Immix Biopharma, Inc. Common Stock
PHARMACEUTICAL PREPARATIONS
Best Pharmaceutical Stocks 2026 →
Immix Biopharma (IMMX) Stock: Buy, Sell, or Hold?
$7.84
-0.23 (-2.85%)
âŧ
5d:
-2.73%
30d:
-9.68%
90d:
-30.86%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (75%)
Quality Score
52/100
Position
FAIR
30-Day Fair Range
$7.77 â $9.37
Position: FAIR
Forward P/E & Valuation
-8.3x
Next 12M consensus est.
Wall Street Target
$24.05
+206.8% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$7.12 / $8.89
Trend: Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
âšī¸ NEUTRAL: IMMX is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
Get Alerted When IMMX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: IMMX is currently trading at $7.84, which is considered fair relative to its 30-day fair value range of $7.77 to $9.37.
Technical Outlook: Technically, IMMX is in a downtrend. Immediate support is located at $7.12, while resistance sits at $8.89.
Market Sentiment: The stock scores a mixed 46/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $24.05 (+206.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, IMMX is in a downtrend. Immediate support is located at $7.12, while resistance sits at $8.89.
Market Sentiment: The stock scores a mixed 46/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $24.05 (+206.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$7.77 -
$9.37
Company Quality Score
52/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
74.7%
Trading Range & Key Levels
30-Day Trading Range
$7.77 -
$9.37
Current vs Trading Range
FAIR
Support Level
$7.12
Resistance Level
$8.89
Current Trend
Downtrend
Technical data as of
Nov 13, 2026
Quantitative Signal Breakdown
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (46/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 206.8% below Wall St target ($24.05)
- WARNING: Composite score 52/100 in the bottom quintile â this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
-8.27
Wall Street Target
$24.05
(+206.8%)
Share IMMX Analysis
Share this live IMMX analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (IMMX)
Neutral
1 Retail Mentions
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Nov 6, 2026
Daily AI digest
AI Retail Discussion Summary:
A bullish StockTwits message indicates excitement about incoming automatic cleared house (ACH) transfers to Schwab related to $IMMX, with no new information from Yahoo Finance.
Key Retail Themes:
Anticipation of positive news or investment inflows
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 13, 2026 5:28 PM ET
Data refreshes hourly during market hours. Next update: 6:28 PM
Data refreshes hourly during market hours. Next update: 6:28 PM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is IMMX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
CYTK
Cytokinetics Inc |
STRONG BUY
22 analysts |
$107 | 69 BUY |
|
ONC
BeOne Medicines AG |
STRONG BUY
27 analysts |
$438 | 36 SELL |
|
INSM
Insmed Inc |
STRONG BUY
24 analysts |
$194 | 41 HOLD |
|
MDGL
Madrigal PharmaceuticalsâĻ |
STRONG BUY
19 analysts |
$689 | 48 HOLD |
|
PVLA
Palvella Therapeutics, IâĻ |
STRONG BUY
16 analysts |
$233 | 48 HOLD |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive IMMX Research Pages
